INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

Capsular polysaccharide is a major virulence factor of Neisseria meningitidis. Of the 12 different meningococcal capsular polysaccharides so far defined, 5 (serogroups A, B, C, Y, and W-135) are most often associated with invasive disease. With the exception of serogroup A, these capsules are polymers of or contain sialic acid. Capsular polysaccharides protect the meningococcus from a variety of cellular and humoral host immune defenses, including phagocytosis, opsonization, and complement-mediated killing (16, 17), and allow survival during invasive meningococcal disease. In addition, the (28)-linked polysialic acid capsule of serogroup B meningococci is a poor immunogen due to structural identity with surface antigens of human tissues such as the neural cell adhesion molecule N-CAM (34). Capsules also have an important role in meningococcal transmission by facilitating loss of meningococci from human mucosal surfaces and protecting the organism from environmental stress. During other events in human pathogenesis (e.g., nasopharyngeal colonization and attachment to epithelial and endothelial cells), meningococci that have downregulated or switched off capsule are selected (27, 35-37).

The genetic basis for the control of expression of meningococcal capsule has been partially elucidated. Frosch et al. (9) identified a 24-kb cps gene complex that encodes factors necessary for the expression of serogroup B capsule when cloned into Escherichia coli. We also defined this region in N. meningitidis by Tn916 mutagenesis (28, 30, 33). Subsequent work has identified the genetic basis for the different meningococcal capsular polysaccharides (5, 32) and shown that regions A and C of the cps complex are critically involved in expression of the serogroups A, B, C, Y, and W-135 capsules (30, 32). For the sialic acid capsule-producing meningococci, region A consists of four polycistronic capsule biosynthetic genes, synABCD, while region C contains ctrABCD, responsible for capsule transport across the inner and outer membranes (Fig. 1A). We have shown that synABCD and ctrABCD are operons separated by a 134-bp intergenic region that contains putative promoters that initiate divergent transcription from adjacent start sites (Fig. 1B). Examination of the nucleotide sequences surrounding the transcriptional start sites (30) of both operons showed that the synA promoter had identity with the ⁷⁰ class of constitutive promoters, while ctrA was preceded by a perfect 10 extended promoter (19). Transcriptional activity of the putative promoters was confirmed when they were cloned in front of a lacZ reporter in E. coli, with the synA promoter exhibiting higher activity (30).

View larger version (44K): [in this window] [in a new window]   FIG. 1.   (A) Schematic diagram of region A (biosynthesis operon, synA/B/C/D) and region C (capsule transport operon, ctrA/B/C/D) of the capsule locus in N. meningitidis with the locations of Tn916 mutations (700, M7, and 43) noted (30). Arrows indicate the directions of transcription and the start codons of synA and ctrA separated by a 134-bp intergenic region. (B) Nucleotide sequence of the intergenic region from 95 to +145 of synA is shown. The 10 and 35 elements of the synA promoter are indicated above the sequence, while the extended 10 (10x) sequence of ctrA is indicated below the sequence. The start codons for synA (ATG) and ctrA (GTG) are boxed. A vertical line marks the adjacent transcription initiation sites. The deletions of this region in mutants S(C)A286(86), S(C)A293(93), and S(C)A233(33) are indicated by broken lines underneath the sequence, and the base substitutions (GGCCC) in mutant S(C)A247 are specified below the sequence. Solid arrows above the sequence show the locations of inverted (IR) and direct (DR) repeats. Putative IHF binding sites are shaded in gray.

In this study we further investigated the hypothesis that the intergenic region separating the biosynthetic and capsule transport operons is critical for transcriptional regulation of serogroup B meningococcal capsule expression. Deletion, insertion, and site-directed mutagenesis of the intergenic region was performed, and transcriptional reporter gene fusions were constructed in order to define the role of the region in transcriptional regulation of meningococcal capsule expression.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Strains and growth conditions. Strains used in this study are listed in Table 1. Meningococcal strains were grown on GC base agar (Difco Laboratories) supplemented with glucose and iron at 37°C with 3.5% carbon dioxide. Liquid cultures were vigorously aerated in GC broth with the same supplements and 4.3% sodium bicarbonate at 37°C. -Galactosidase expression in reporter constructs was assayed using the Miller method (21). Meningococcal transformants containing the lacZ-ermC constructs were selected and maintained in the presence of erythromycin (3 µg/ml) (Sigma). E. coli strains were grown in Luria-Bertani (LB) broth (Bethesda Research Laboratories) at 37°C with appropriate antibiotic selection (erythromycin, 300 µg/ml; spectinomycin, 100 µg/ml; kanamycin, 50 µg/ml; and ampicillin, 100 µg/ml).

Transformation. Meningococci were transformed with DNA by the technique of Janik et al. (15). E. coli transformation was performed using the chemical transformation method described by Chung and Miller (4) or electroporation with a GenePulser (Bio-Rad).

DNA constructs. To create mutations in the 134-bp intergenic region, a 900-bp PCR product of primers LJ4 and JS44 (Table 2), containing the intergenic region and the 5' ends of both the ctrA and synA genes, was cloned into pCR2.1 (Invitrogen) or pGEM-T (Promega), yielding pTINT and pGINT, respectively. An -spectinomycin cassette with strong transcriptional and translational terminators on either side was obtained from pHP45 (23). A SmaI fragment of  was inserted into the SnaBI site of pTINT and the EcoRI- fragment was inserted into the EcoRI site of pGINT to generate pINT1 and pINT2, respectively. These plasmids were used to transform N. meningitidis strain NMB, and the spectinomycin-resistant transformants NMBINT1 and NMBINT2, respectively, were isolated. To create the NMBINT1 mutant, a ligation of the LJ4-JS75 and JS74-JS44 PCR products was used as a template and reamplified with external primers LJ4 and JS44. The resulting PCR product of the expected size was cloned into pCR2.1, and the  cassette was subsequently inserted into the SnaBI site to give pINT1. pINT1 was then used to transform strain NMB as described above. Analogously, the NMBINT2 mutant was generated by the LJ4-JS94 and JS93-JS73 pairs and cloned into pGEM, followed by the insertion of the  cassette into the EcoRI site. The mutations were verified by PCR amplification, Southern hybridization, and sequencing analysis.

RNA isolation and slot blots. Total RNA was purified according to the published procedure (30). RNA samples were denatured in 500 µl of cold denaturing buffer (10 mM NaOH, 1 mM EDTA) and immediately transferred to a Zeta-Probe GT membrane with a PR648 slot blot filtration manifold (Hoefer Scientific). The wells were rinsed once with 500 µl of denaturing buffer. The blotted membrane was rinsed in 2X SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% sodium dodecyl sulfate (SDS) before prehybridization for 5 min at 65°C in P buffer, composed of 0.5 M NaHPO₄ (pH 7.2), 1 mM EDTA, and 7% SDS. The membrane was hybridized with denatured DNA probe in P buffer overnight at 65°C. After hybridization, the membrane was washed twice in E buffer (40 mM NaHPO₄ [pH 7.2], 1 mM EDTA) containing 5% SDS and then twice in E buffer with 1% SDS, all at 65°C. The membrane was then subjected to autoradiography. The probe for synA transcription was PCR amplified from chromosomal DNA using JS44 and JS86 and labeled by random-primed labeling (Boehringer Mannheim) with [³²P]dATP (NEN DuPont).

Colony immunoblots. Colony immunoblots were performed essentially as described by Swartley et al. (30). Wild-type strain NMB served as the positive control for encapsulation, while the capsule-negative mutant strain M7 (28) was the negative control. The primary anti-serogroup B capsular monoclonal antibody 2-2-B was generously supplied by Wendell Zollinger (Walter Reed Army Institute of Research). The secondary antibody was goat anti-mouse immunoglobulin M (IgM)-IgG-alkaline phosphatase conjugate (Jackson Immunochemicals). The membranes were developed with NBT-BCIP (nitroblue tetrazolium-5-bromo-4-chloro-3-indolylphosphate).

Whole-cell ELISA. Serogroup B capsule-specific monoclonal antibody 2-2-B was employed in the whole-cell enzyme-linked immunosorbent assay (ELISA) following the published protocol (31) with minor modifications; 100 µl of a 1:3 dilution of the cell suspension (optical density at 650 nm [OD₆₅₀] = 0.1) was added to the microtiter plates. Incubation was done at 37°C instead of 33°C.

Statistical analysis. Student's t test with a two-tailed hypothesis was used to determine the significant difference (P  0.05) between two variables in these studies.

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

Insertion and deletion mutagenesis confirmed that the ctrA-synA intergenic region is required for production and expression of serogroup B meningococcal capsular polysaccharide. A series of controlled deletion and -spectinomycin cassette insertions in the 134-bp ctrA-synA intergenic region were created as described in Materials and Methods and are shown schematically in Fig. 2A. The production and expression of capsule were quantified by whole-cell ELISAs using monoclonal antibody 2-2-B, and the results are shown in Fig. 2B. The mutations within the intergenic region eliminated or dramatically reduced capsular polysaccharide expression (P < 0.006 for each mutant), indicating the essential role of this region in controlling the production and transport of capsule.

View larger version (25K): [in this window] [in a new window]   FIG. 2.   (A) Schematic diagram of the capsule biosynthesis and transport operon intergenic region. The locations of various primers (half-arrows) used in this study are noted below the diagram. The shaded bar is the 134-bp intergenic region between the two start codons of synA and ctrA. Base numbering is from the corresponding transcriptional start sites, which are indicated by bent arrows. The repeats examined in mutagenesis studies are also shown as arrows. The  cassette was inserted into the SnaBI site within the 5' UTR of synA in the two INT1 constructs, whereas the two INT2 constructs were created with the  cassette inserted at the start of the coding sequence. In addition, the sequence between primers JS75 and JS74 was deleted in the INT1 strain, while the sequence between JS94 and JS93 was removed in the INT2 construct. (B) Capsule whole-cell ELISA of wild-type strain NMB and meningococcal mutants INT1, INT2, INT1, and INT2. An unencapsulated synA::Tn916 mutant (28) was used as the negative control. A ctrA::Tn916 mutant, 700 (30), is included for comparison. Results are shown as the average values from three independent experiments.

Transcription of ctr and syn operons is initiated from the intergenic region. The capsule-specific ELISA results suggested that capsule production is initiated within the intergenic region through transcriptional activation of the syn and ctr operons. To further confirm this hypothesis, changes in synA transcriptional level were examined by RNA slot blots. As shown in Fig. 3, the mutations within the 134-bp intergenic region reduced synA RNA expression. However, the synA mRNA signal from the ctrA mutant 700 (ctrA::Tn916), in which the transposon was at the bp 285 location of ctrA (285 bp relative to the transcriptional start site of synA), yielded a synA mRNA signal similar to that of the wild-type strain. This result indicated that the 285-bp sequence upstream of the synA transcriptional start site was sufficient to control synA expression and the inactivation of ctrA had no significant influence on synA transcription.

View larger version (62K): [in this window] [in a new window]   FIG. 3.   RNA slot blots of synA transcription. Total-cell RNA was purified from parental strain NMB and mutants INT1, INT2, INT1, and INT2, as described in Materials and Methods. The mRNA level of recA was also measured and used as a control for RNA loading.

syn promoter is constitutively more active than ctr promoter, and transcription from both promoters is growth phase dependent. To further investigate the relative strength and possible mechanisms of regulation of the syn and ctr promoters, a lacZ-ermC cassette was inserted downstream of both promoters, creating transcriptional reporter strains. Two syn reporter strains were constructed, one with lacZ inserted in the synA coding region (SA2), and the other with lacZ in the 5' untranslated region (UTR) of synA (SA1) (Fig. 2A). The ctr promoter strain (CA2) contained lacZ in the coding region. Overnight cultures of the meningococcal reporter strains were diluted into fresh GC broth and grown with aeration at 37°C, and the expression of -galactosidase activity was monitored (Fig. 4A). The ctr promoter reporter strain (CA2) produced low levels of activity that increased moderately (~2-fold) when entering the stationary phase. The SA2 syn construct gave an expression pattern similar to that of CA2, but was about fourfold higher (P < 0.05). The SA1 syn construct consistently yielded ~2-fold higher activity than that of the SA2 reporter strain throughout growth (P < 0.05). These results suggested that the sequence between the insertion sites of SA1 and SA2 had a negative or downregulating role in syn transcription, yet the growth phase-dependent regulation was not located in this region, since SA1 still produced an ~2-fold increase in the stationary phase.

View larger version (27K): [in this window] [in a new window]   FIG. 4.   (A) Expression of a lacZ reporter located in synA in SA1 (diamonds) or SA2 (squares) or in ctrA in CA2 (triangles) during growth. Each time point shows the average value of three experimental measurements, and data are representative of three independent assays. (B) Expression of synA::lacZ reporters during mid-log growth phase (OD550  0.5) in different meningococcal backgrounds: 1, SA2, wild type; 2, SA2 in a ctrA:: background; 3, SA295, synA::lacZ with 95 to +339 promoter fragment of synA fused with lacZ-ermC and integrated into a noncoding chromosomal locus and retaining an intact capsule A and C region; 4, SA295 in a synA::Tn916 background; 5, lacZ-ermC cassette without promoter integrated into the same locus as SA295.

Determination of minimal promoter region required for syn transcription. As described above, a Tn916 insertion (ctrA mutant 700) at bp 285 of the synA transcription start site did not alter the synA mRNA level in RNA slot blot experiments (Fig. 3). This result was also confirmed by the transcriptional reporter assays. As shown in Fig. 4B, the SA2 syn reporter produced similar activity in either the wild-type or ctrA:: background, indicating that no cis element was present beyond 285 bp. To confirm these results, a lacZ transcriptional fusion construct of synA was also generated at a distant heterologous chromosomal locus, site 120A1, which has no intrinsic promoter activity. This construct, SA295, has an intact capsule locus and contains at the distant site the lacZ reporter and the 95 bp upstream sequence of the synA transcriptional start site. The SA295 construct had ~80% of the transcriptional activity of the SA2 strain. These results suggested that most of the required cis transcriptional determinants for the syn operon resided in the 95 bp upstream of the synA transcriptional start site.

syn and ctr operons do not appear to be influenced by product inhibition or feedback regulation. Many biosynthesis pathways utilize product inhibition or feedback regulation to control overall transcription and product synthesis. For example, the expression of capsule transport proteins could be regulated by the biosynthesis operon substrates (e.g., expression of the ctrABCD transport operon may be influenced by the amount of sialic acid or capsule polymer synthesized by the synABCD gene products). To test whether feedback regulation influenced the meningococcal capsule region, ctr transcriptional fusions were generated in backgrounds with biosynthesis operon mutations, synA::Tn916, synC:: or synD::Tn916, and the corresponding transcriptional activity was compared to that in constructs without these mutations. No significant difference in transcriptional activities was noted in these backgrounds (data not shown). Similarly, disruption of ctrA with insertion of an  cassette did not affect syn operon expression (Fig. 4B). In addition, the production and expression of capsule did not influence syn operon expression, since the distant-site SA295 syn construct had similar activity in encapsulated and unencapsulated (synA::Tn916) backgrounds (Fig. 4B). Finally, the inactivation of polysialyltransferase (synD::Tn916) did not affect the transcription of the syn (SA2) reporter construct (data not shown). Overall, these results indicated that, at least under in vitro growth conditions, the ctr and syn operons did not exhibit evidence of product or feedback regulation.

5' UTR of synA inhibits both syn and ctr operon transcription. A transcription-regulatory role of the 5' UTR sequence of synA was suggested because of the difference in transcription between the SA1 and SA2 syn constructs (Fig. 4A). Additional mutations were generated in this region to further characterize important elements. A 16-bp direct repeat (+78 to +93 relative to the synA transcriptional start site) and a 20-bp inverted repeat (+108 to +127) were identified within the sequence between the SnaBI and the EcoRI sites (Fig. 1B). In addition, several putative integration host factor (IHF) binding sites were identified in the intergenic region using the E. coli IHF consensus sequence 5'-YAANNNNTTGATW-3' (where Y is C/T, W is A/T, and N is G/A/T/C), three of these overlapped either the direct or inverted repeat. Specific deletions that removed either the direct (mutants SA293 and CA293) or inverted (mutants SA233 and CA233) repeat or both repeats (mutants SA286 and CA286) were made in both syn and ctr reporter strains (Fig. 1B and 5). In addition, a 5-base substitution disrupting the symmetry of the direct repeat (mutants SA247 and CA247) was also generated in the reporter strains.

View larger version (38K): [in this window] [in a new window]   FIG. 5.   Transcriptional activities of synA::lacZ (SA2) and ctrA::lacZ (CA2) reporters in N. meningitidis containing mutations within 5' UTR of synA. The mutations are shown in the diagram at the top and also noted in Fig. 1B. Each strain was grown in GC medium to mid-exponential phase, and -galactosidase activities were assayed by the method of Miller (21). The values are presented as the percentage of the wild-type activity (SA2, 929.2 ± 158.0 U; CA2, 227.0 ± 29.8 U). Data shown are the averages of at least three independent experiments. Two-tailed unpaired Student's t test indicated that values for all mutants except SA293 and CA233 are statistically significantly different from that of the wild-type parent strain (P < 0.05).

No inhibition of synA and ctrA transcription by the 5' UTR of synA in an E. coli K1 background. The identical capsule [(28)-linked polysialic acid] expressed by serogroup B meningococci is expressed in E. coli K1 strains. The E. coli K1 strain is the etiologic agent of human neonatal meningitis, and the K1 capsule locus has been extensively investigated (38). Meningococcal capsular biosynthesis and transport gene homologues have been identified in the K1 E. coli strain. In order to examine if the meningococcal regulation machinery was present in this genetic background, the intergenic region was fused with a promoterless lacZ gene (pBlue-Topo), subcloned into a pBR322-derived plasmid (pHP45), and transformed into a clinical isolate of the K1 strain, CAB1. The 5' end of the promoters contained the sequence downstream of the SspI site in ctrA, defined above as being of sufficient promoter length for controlling syn expression. The 3' end of the promoters corresponded to either the SA1 or SA2 meningococcal construct, respectively. The SA1 construct should have higher activity than the SA2 construct if analogous regulation is present in the K1 strain. However, SA1 and SA2 produced similar activity in the E. coli K1 background (Fig. 6), indicating that the regulatory mechanisms that yield higher activity in the SA1 construct were absent in the E. coli K1 strain.

View larger version (12K): [in this window] [in a new window]   FIG. 6.   Expression of synA::lacZ transcriptional fusions in genetic backgrounds of meningococcal strain NMB (solid symbols) and E. coli K1 strain CAB1 (open symbols). Meningococcal reporter strains SA2 (solid squares) and SA1 (solid diamonds) have a lacZ-ermC cassette recombined in the synA locus on the chromosome, while E. coli strains contain a low-copy-number plasmid with the promoter fusion of lacZ corresponding to that of SA2 (open squares) and SA1 (open diamonds). Each time point was measured in triplicate, and the results of one representative experiment are presented.

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

Recent studies have genetically and biochemically characterized the capsule transport ctrABCD and biosynthesis synABCD(E, F) operons of the cps gene complex in serogroups B, C, Y, and W-135 N. meningitidis (5, 9, 30-33). Insertional mutagenesis of genes required for capsule biosynthesis and capsule transport produces unencapsulated phenotypes, confirming the necessity of these genes (30). A number of studies have indicated that the expression of meningococcal capsules is closely associated with virulence (16-18) but that capsule may not be constitutively expressed on the meningococcal surface (27, 35-37). These data indicate that expression of capsule is subject to regulation.

Capsule expression in N. meningitidis is known to be controlled through genetic on-off switch mechanisms and possibly through posttranscriptional modification. Two kinds of on-off switch mechanisms of meningococcal capsule expression have been defined. Reversible insertion and the excision of a naturally occurring insertion element, IS1301, into synA have been shown in a serogroup B strain, B1940 (11). Other IS1301 insertions in the capsule biosynthesis operon eliminate capsule expression (32; J. Dolan-Livengood and D. S. Stephens, unpublished data). In addition, a poly(C) track within synD, the polysialyltransferase, of serogroup B strains alters capsule expression at a frequency of 10³ through a slipped-strand mispairing mechanism (12). Finally, enzymatic activity of a CMP-sialic acid hydrolase has been detected in meningococcal cell extracts and is proposed to be a posttranscriptional regulatory mechanism for meningococcal capsular polysaccharide (20).

We found that transcriptional regulation is also a pathway for control of sialic acid capsule expression in N. meningitidis. We have previously shown that the first genes of the biosynthesis and transport operons, synA and ctrA, respectively, are transcribed divergently from abutting start sites located in a 134-bp intergenic region. Furthermore, the sequence of this intergenic region is identical among all serogroups synthesizing capsules containing sialic acid (30). The data presented in this report confirm that the 134-bp intergenic region contains the promoters of these operons and identifies other transcriptional regulatory elements of serogroup B meningococcal capsule expression. Coordinate transcriptional regulation of divergent promoters in bacterial pathogens is well described. In Vibrio cholerae, for example, two virulence genes, acfA and acfD, are transcribed in opposite directions from a 173-bp intergenic region (8). Expression of these genes is under the coordinate control of ToxR, which activates the promoter of acfD and represses acfA transcription.

The syn and ctr promoters present in the 134-bp intergenic region were both capable of actively transcribing lacZ in the meningococcus. The ctr promoter produced lower levels of lacZ transcription than the syn promoter in a meningococcal background, confirming previous work with these promoters in E. coli (30). The syn promoter is a near consensus ⁷⁰-type promoter, while the ctr promoter is similar to the 10 extended promoter class, originally identified in work with lambdoid phages in E. coli, and lacks a consensus 35 recognition sequence (19). Under most conditions, RNA polymerase would be predicted to bind tightly to the consensus ⁷⁰ syn promoter, instead of the 10 extended ctr promoter, and thus transcribe the biosynthesis operon more efficiently. Sialic acid, which is synthesized by SynA/B/C proteins of the biosynthesis operon, is used for lipooligosaccharide (LOS) sialylation as well as capsule polymerization. This might explain why the syn promoter is constitutively expressed at a high level. Indeed, a mutation that inactivates the serogroup B meningococcal polysialyltransferase shifts the partially sialylated LOS of the wild-type parent strain to a fully sialylated LOS (18) and indicates shunting of sialic acid into the LOS pathway when capsule expression is blocked. Since the only known function of the proteins encoded by the capsule transport operon appears to be transport of the assembled capsule polymers, these proteins may not need to be expressed in high quantity.

A relatively small (<200 bp) upstream region controls the syn operon. This mechanism is not uncommon. The production of an exopolysaccharide by the phytopathogen Pseudomonas solanacearum is accomplished by an 18-kb gene cluster that is controlled by a 140-bp region upstream of the transcription start site and a multicomponent regulatory network (14). The regulation of bundle-forming pili in enteropathogenic E. coli is controlled by the sequence within 95 bp upstream of the transcriptional start point (24).

In addition to the promoters, we identified within the 134-bp region a 70-bp sequence of the 5' UTR of synA that influences both ctr and syn promoter activity. A 20-bp inverted repeat of this region, which includes the synA start codon, was suggested as a possible regulatory element for transcription of syn and ctr operons (6). In Neisseria gonorrhoeae and N. meningitidis, a 16-bp inverted repeat encompassing the putative ribosome-binding site of the rfaC gene, encoding the LOS 1,5-heptosyltransferase I, is involved in the transcriptional regulation of this gene (40). Deletion of the 20-bp inverted repeat sequence moderately decreased syn transcription but had no effect on ctr expression. In contrast, deletion of a 16-bp direct repeat which precedes the ribosome-binding site enhanced both ctr and syn expression. Interestingly, our laboratory had previously shown that clinical meningococcal isolates occur with deletions in the direct repeat. For example, a serogroup W-135 strain was found to have an 8-bp deletion and 2-nucleotide substitution in the direct repeat (30). The elimination of the direct repeat element in vivo would be predicted to upregulate syn and ctr promoter activities and capsule expression in meningococci.

A 70-bp deletion that removed both the inverted and direct repeats produced the most significant increase in transcription, suggesting that the combination of the direct and inverted repeats facilitated the greatest repression of transcription of the syn and ctr operons. An arrangement similar to this direct-inverted repeat motif is found downstream of the vrg promoters in Bordetella pertussis and is thought to be the target for a transcriptional repressor that binds to this region and prevents transcription (2). This direct-inverted repeat sequence may also assume a topology that interferes with RNA polymerase binding, and the removal of this region enhances the efficiency of the transcription complexes. Alternatively, the sequence within the 5' UTR of synA may influence the stability of mRNA and therefore modulate the transcriptional level of syn genes. Interestingly, three putative IHF binding motifs were also identified within the 70-bp region. IHF is known to bend DNA within the promoter region and modulate transcription (10). The involvement of IHF in the regulation of K5 capsule gene clusters in pathogenic E. coli has recently been reported (26).

Two-component regulatory systems have been identified that control capsular polysaccharide production and expression in bacterial pathogens. For example, the colanic acid capsule of E. coli is controlled by the RcsB-RcsC two-component system (29), while the AlgQ-AlgR system controls the alginate capsule in Pseudomonas aeruginosa (7) and the CsrR-CsrS system is involved in hyaluronic acid capsule production in Streptococcus pyogenes (13). In preliminary studies, we have not found that transcription of the sialic acid-containing meningococcal capsules is influenced by environmental conditions that act as triggers for two-component regulatory systems. Changes in temperature, pH, osmolarity, iron, carbon source, and serum exposure have not affected syn or ctr transcription. In support of these observations, only four putative response regulators in the serogroup A and serogroup B meningococcal genomes have been noted. In contrast, E. coli and Bacillus subtilis have 34 and 35 response regulator proteins, respectively. Mutations in three of the putative meningococcal two-component regulatory systems showed no effect in syn or ctr transcription (Y.-L. Tzeng and D. S. Stephens, unpublished data).

We did find that transcription of the syn operon occurs at the highest levels during the stationary phase of the meningococcal growth curve. The increase in synthesis of sialic acid for incorporation into the LOS or the polysialic acid capsule pathway appears greatest during the later stages of the bacterial growth curve. In the plant pathogen Erwinia stewartii, a homoserine lactone autoinducer is required for the induction of capsule biosynthesis (3). The possibility of a quorum-sensing mechanism regulating capsule expression in N. meningitidis will require further study.

In summary, expression of the sialic acid capsule of N. meningitidis is initiated by divergent promoters located within a 134-bp intergenic region separating the biosynthesis and transport operons. Transcription of these operons is repressed by a 70-bp 5' UTR of synA, is increased during stationary growth, and shows species-specific regulation. The 134-bp synABCD-ctrABCD intergenic region is an important control point for the transcriptional regulation of sialic acid capsule expression.